SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-066367
Filing Date
2024-08-08
Accepted
2024-08-08 09:44:08
Documents
14
Period of Report
2024-08-07
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0210868-8k_aditxt.htm   iXBRL 8-K 55404
2 CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION FILED AND EFFECTIVE WIT ea021086801ex3-1_aditxt.htm EX-3.1 5330
  Complete submission text file 0001213900-24-066367.txt   242612

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE adtx-20240807.xsd EX-101.SCH 3009
4 XBRL LABEL FILE adtx-20240807_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE adtx-20240807_pre.xml EX-101.PRE 22355
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0210868-8k_aditxt_htm.xml XML 3901
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 241186443
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)